- Home
- HLLY vs OLMA Comparison
HLLY vs OLMA Comparison
Compare HLLY & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HLLY | OLMA |
|---|---|---|
| Founded | 1903 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.4M | 725.5M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | HLLY | OLMA |
|---|---|---|
| Price | $4.27 | $33.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | $4.43 | ★ $40.50 |
| AVG Volume (30 Days) | 845.2K | ★ 8.5M |
| Earning Date | 11-07-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $598,132,000.00 | N/A |
| Revenue This Year | $1.75 | N/A |
| Revenue Next Year | $5.07 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.60 | $2.86 |
| 52 Week High | $4.43 | $33.50 |
Technical Indicators
Market Signals| Indicator | HLLY | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 63.99 | 82.93 |
| Support Level | $4.01 | $25.62 |
| Resistance Level | $3.90 | $33.50 |
| Average True Range (ATR) | 0.16 | 2.25 |
| MACD | -0.03 | 0.27 |
| Stochastic Oscillator | 71.55 | 96.91 |
Price Performance
Historical ComparisonAbout HLLY Holley Inc.
Holley Inc is a designer, marketer, and manufacturer of high-performance automotive aftermarket products, featuring a portfolio of iconic brands serving the car and truck industry. It offers a diversified line of performance automotive products including fuel injection systems, tuners, exhaust products, carburetors, safety equipment and various other performance automotive products. The Company's products are designed to enhance street, off-road, recreational and competitive vehicle performance through increased horsepower, torque and drivability. The company's brands include Holley, APR, MSD and Flowmaster, among others. It derives revenue from the U.S. and Italy, of which prime revenue is derived from the U.S.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.